NCT00439192 ELB245 for 12 Weeks Versus 4mg Tolterodine in Patients With Incontinent Overactive Bladder (OAB) Status TERMINATED Phase PHASE2
NCT00392210 Assessment of Two Postoperative Techniques Used to Predict Voiding Efficiency After Gynecologic Surgery Status COMPLETED Phase NA
NCT00376441 Evaluate Women After Vaginal Surgery for Urinary Symptoms and Sexual Function Status COMPLETED Phase N/A
NCT00355433 Comparison of Body and Room Temperature Saline in Urodynamics Status UNKNOWN Phase PHASE4
NCT00345332 A Multi-Center Trial of Botox for Severe Urge Urinary Incontinence Status COMPLETED Phase NA
NCT00337558 A Study of Solifenacin With Bladder Training Versus Solifenacin Alone in Patients With Overactive Bladder (SOLAR) Status COMPLETED Phase PHASE4
NCT00333112 A Study to Evaluate Solifenacin Succinate in Combination With Tamsulosin for the Treatment of Residual Overactive Bladder Symptoms (OAB) in Men. Status COMPLETED Phase PHASE4
NCT00333073 Effectiveness and Safety of Bulkamid® as Bulking Agent for the Treatment of Female Urinary Incontinence Status COMPLETED Phase NA
NCT00323635 A Comparison of Tolterodine and Placebo Treatments on Nocturnal Frequency and Sleep Quality in Women After Menopause. Status TERMINATED Phase PHASE4
NCT00323245 Regaining Bladder Control in Postmenopausal Women With Osteoporosis Status COMPLETED Phase NA
NCT00304499 Efficacy and Safety of OROS Oybutynin and TTS Oxybutynin in Middle-Aged and Elderly Women With Urinary Incontinence Status COMPLETED Phase PHASE3
NCT00293839 Efficacy and Tolerability of DITROPAN XL (Oxybutynin Chloride) Versus DETROL LA (Tolterodine Tartrate) in Treatment of Overactive Bladder Status COMPLETED Phase PHASE3
NCT00290563 Safety and Efficacy of MK0594 to Treat Overactive Bladder (0594-003) Status COMPLETED Phase PHASE2